Total Funding
65
74
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
16436
Encodia is a biotech company that develops the next generation of protein analysis tools.
Michael Weiner: Co-FounderPast Role: Ares Capital, Vice President, General Counsel & Chief Compliance Officer
Julie Sunderland: Co-Founder & Board MemberPast Role: Guide Therapeutics, Executive Chairwoman
About the Company
Encodia provides in-depth information on cellular processes to enable personalized medicine.
Our technology reverse translates peptide sequence information into a DNA library. This means scientists can scale their research more easily to accelerate novel approaches to our most challenging diseases.
Encodia was established on January 1, 2015 in
San Diego, California.
Women Founded
